ADC Therapeutics SA is a clinical-stage biotechnology company, which develops antibody drug conjugates. Its products include Lonca, Cami and ADCT-602. Its drugs are used in treating various advanced solid tumors. The company was founded on June 6, 2011 and is headquartered in Epalinges, Switzerland.
$24.34 +1.61 (7.08%)
As of 04/14/2021 16:00:02 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.